<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Onco-innovations Ltd. — News on 6ix</title>
    <link>https://6ix.com/company/onco-innovations-ltd-1</link>
    <description>Latest news and press releases for Onco-innovations Ltd. on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Thu, 09 Apr 2026 12:30:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/onco-innovations-ltd-1" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d6af8fbeedb30cb6ff9607.webp</url>
      <title>Onco-innovations Ltd.</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1</link>
    </image>
    <item>
      <title>Onconetix Highlights Realbotix&apos;s Launch of Vinci AI Vision System with Delivery of First Vinci-Equipped Humanoid Robot to Ericsson</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-highlights-realbotixs-launch-of-vinci-ai-vision-system-with-delivery-of-first-vinci-equipped-humanoid-robot-to-ericsson-1</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-highlights-realbotixs-launch-of-vinci-ai-vision-system-with-delivery-of-first-vinci-equipped-humanoid-robot-to-ericsson-1</guid>
      <pubDate>Thu, 09 Apr 2026 12:30:00 GMT</pubDate>
      <description>Vinci Enables Realbotix Robots to Recognize People, Recall Conversations, and Track Engagement; O...</description>
    </item>
    <item>
      <title>Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-highlights-realbotix-ai-humanoid-robot-delivery-update-45</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-highlights-realbotix-ai-humanoid-robot-delivery-update-45</guid>
      <pubDate>Thu, 02 Apr 2026 12:30:00 GMT</pubDate>
      <description>Realbotix Announces Expected Delivery of 19 Robots in March, April, and May 2026 as it Scales Pro...</description>
    </item>
    <item>
      <title>Onconetix Appoints David White as Chief Executive Officer and Sammy Dorf as Member of the Board of Directors</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-appoints-david-white-as-chief-executive-officer-and-sammy-dorf-as-member-of-the-board-of-directors</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-appoints-david-white-as-chief-executive-officer-and-sammy-dorf-as-member-of-the-board-of-directors</guid>
      <pubDate>Tue, 31 Mar 2026 12:30:00 GMT</pubDate>
      <description>Experienced Leadership Team Positioned to Execute Pending Transformative Acquisition of Realbotix...</description>
    </item>
    <item>
      <title>Onconetix Highlights Realbotix&apos;s Role in Ericsson&apos;s World-First 6G Trial Demonstration</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-highlights-realbotixs-role-in-ericssons-world-first-6g-trial-demonstration</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-highlights-realbotixs-role-in-ericssons-world-first-6g-trial-demonstration</guid>
      <pubDate>Wed, 25 Mar 2026 16:47:00 GMT</pubDate>
      <description>Realbotix Humanoid Robot &amp;#x2014; Ericsson&amp;#x2019;s First Enterprise Robotics Client &amp;#x2014; Fea...</description>
    </item>
    <item>
      <title>Onconetix, Inc. Announces 1-for-5 Reverse Stock Split</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-inc-announces-1-for-5-reverse-stock-split</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-inc-announces-1-for-5-reverse-stock-split</guid>
      <pubDate>Mon, 23 Mar 2026 12:30:00 GMT</pubDate>
      <description>CINCINNATI, Ohio, March 23, 2026 (GLOBE NEWSWIRE) -- Onconetix, Inc. (NASDAQ: ONCO) (&amp;#x201C;Onco...</description>
    </item>
    <item>
      <title>Onconetix to Acquire Realbotix LLC, USA-based, AI-Powered Humanoid Robotics Company</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-to-acquire-realbotix-llc-usa-based-ai-powered-humanoid-robotics-company</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-to-acquire-realbotix-llc-usa-based-ai-powered-humanoid-robotics-company</guid>
      <pubDate>Thu, 12 Feb 2026 13:00:00 GMT</pubDate>
      <description>A leading AI and humanoid robotics company has commercially available models designed, built and ...</description>
    </item>
    <item>
      <title>Realbotix Corp. Announces the Sale of Realbotix, LLC Subsidiary to a NASDAQ Listed Issuer</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/realbotix-corp-announces-the-sale-of-realbotix-llc-subsidiary-to-a-nasdaq-listed-issuer-1</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/realbotix-corp-announces-the-sale-of-realbotix-llc-subsidiary-to-a-nasdaq-listed-issuer-1</guid>
      <pubDate>Thu, 12 Feb 2026 13:00:00 GMT</pubDate>
      <description>Realbotix Corp. (TSX-V: XBOT) (Frankfurt: 76M0.F) (OTC: XBOTF) (&amp;#x201C;Realbotix&amp;#x201D; or the ...</description>
    </item>
    <item>
      <title>Novel Cancer Platforms Converge as Clinical Data Reshapes Treatment Paradigms</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/novel-cancer-platforms-converge-as-clinical-data-reshapes-treatment-paradigms</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/novel-cancer-platforms-converge-as-clinical-data-reshapes-treatment-paradigms</guid>
      <pubDate>Tue, 07 Oct 2025 12:00:00 GMT</pubDate>
      <description>Novel Cancer Platforms Converge as Clinical Data Reshapes Treatment Paradigms           Canada Ne...</description>
    </item>
    <item>
      <title>Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc.</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-announces-financing-through-a-dollar129-million-private-placement-of-series-d-preferred-stock-and-warrants-termination-of-merger-agreement-with-ocuvex-inc-and-settlement-of-dollar88-million-debt-with-veru-inc</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-announces-financing-through-a-dollar129-million-private-placement-of-series-d-preferred-stock-and-warrants-termination-of-merger-agreement-with-ocuvex-inc-and-settlement-of-dollar88-million-debt-with-veru-inc</guid>
      <pubDate>Fri, 26 Sep 2025 12:30:00 GMT</pubDate>
      <description>CINCINNATI, OH, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (&quot;Onconetix&quot; or...</description>
    </item>
    <item>
      <title>Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/joint-press-release-onconetix-and-ocuvex-announce-mutual-termination-of-merger-agreement</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/joint-press-release-onconetix-and-ocuvex-announce-mutual-termination-of-merger-agreement</guid>
      <pubDate>Fri, 26 Sep 2025 12:15:00 GMT</pubDate>
      <description>CINCINNATI, OH &amp;amp; FORT LEE, NJ, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ON...</description>
    </item>
    <item>
      <title>Onconetix announces its subsidiary, Proteomedix, licenses manufacturing IP to Immunovia enabling them to independently produce key reagents for their pancreatic cancer test PancreaSureTM</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-announces-its-subsidiary-proteomedix-licenses-manufacturing-ip-to-immunovia-enabling-them-to-independently-produce-key-reagents-for-their-pancreatic-cancer-test-pancreasuretm</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-announces-its-subsidiary-proteomedix-licenses-manufacturing-ip-to-immunovia-enabling-them-to-independently-produce-key-reagents-for-their-pancreatic-cancer-test-pancreasuretm</guid>
      <pubDate>Mon, 22 Sep 2025 12:00:00 GMT</pubDate>
      <description>CINCINNATI, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (&quot;Onconetix&quot; or the...</description>
    </item>
    <item>
      <title>$HAREHOLDER ALERT: The M&amp;A Class Action Firm Announces An Investigation of Onconetix, Inc. (NASDAQ: ONCO)</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/dollarhareholder-alert-the-manda-class-action-firm-announces-an-investigation-of-onconetix-inc-nasdaq-onco</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/dollarhareholder-alert-the-manda-class-action-firm-announces-an-investigation-of-onconetix-inc-nasdaq-onco</guid>
      <pubDate>Thu, 17 Jul 2025 16:15:52 GMT</pubDate>
      <description>NEW YORK, July 17, 2025 (GLOBE NEWSWIRE) --         Class Action Attorney       Juan Monteverde  ...</description>
    </item>
    <item>
      <title>ONCO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Onconetix, Inc. Is Fair to Shareholders</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/onco-stock-alert-halper-sadeh-llc-is-investigating-whether-the-merger-of-onconetix-inc-is-fair-to-shareholders</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/onco-stock-alert-halper-sadeh-llc-is-investigating-whether-the-merger-of-onconetix-inc-is-fair-to-shareholders</guid>
      <pubDate>Wed, 16 Jul 2025 14:38:00 GMT</pubDate>
      <description>Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Onconetix, ...</description>
    </item>
    <item>
      <title>Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreement</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-and-ocuvex-therapeutics-announce-execution-of-definitive-merger-agreement</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-and-ocuvex-therapeutics-announce-execution-of-definitive-merger-agreement</guid>
      <pubDate>Wed, 16 Jul 2025 12:17:00 GMT</pubDate>
      <description>CINCINNATI, July 16, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (&amp;#x201C;Onconetix&amp;#...</description>
    </item>
    <item>
      <title>Onconetix, Inc. Announces Positive Decision by Nasdaq Hearings Panel</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-inc-announces-positive-decision-by-nasdaq-hearings-panel</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-inc-announces-positive-decision-by-nasdaq-hearings-panel</guid>
      <pubDate>Mon, 16 Jun 2025 12:22:00 GMT</pubDate>
      <description>CINCINNATI, Ohio, June 16, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (&amp;#x201C;Oncon...</description>
    </item>
    <item>
      <title>Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-inc-announces-1-for-85-reverse-stock-split-and-results-of-the-special-meeting-of-stockholders</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-inc-announces-1-for-85-reverse-stock-split-and-results-of-the-special-meeting-of-stockholders</guid>
      <pubDate>Wed, 11 Jun 2025 15:30:00 GMT</pubDate>
      <description>CINCINNATI, Ohio, June 11, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (NASDAQ: ONCO) (&amp;#x201C;Oncon...</description>
    </item>
    <item>
      <title>Onconetix, Inc. Announces Receipt of Additional Notice from Nasdaq</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-inc-announces-receipt-of-additional-notice-from-nasdaq</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-inc-announces-receipt-of-additional-notice-from-nasdaq</guid>
      <pubDate>Thu, 22 May 2025 20:50:00 GMT</pubDate>
      <description>Cincinnati, OH, May 22, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (the &amp;#x201C;Comp...</description>
    </item>
    <item>
      <title>Onconetix Signs Letter of Intent for Potential Business Combination with Ocuvex Therapeutics, Inc.</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-signs-letter-of-intent-for-potential-business-combination-with-ocuvex-therapeutics-inc</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-signs-letter-of-intent-for-potential-business-combination-with-ocuvex-therapeutics-inc</guid>
      <pubDate>Tue, 08 Apr 2025 12:30:00 GMT</pubDate>
      <description>CINCINNATI, April 08, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (Nasdaq: ONCO) (&amp;#x201C;Onconetix&amp;...</description>
    </item>
    <item>
      <title>Onconetix Announces New Clinical Data for its Innovative Prostate Cancer Test Proclarix Accepted for Presentation at 2025 European Association of Urology Congress</title>
      <link>https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-announces-new-clinical-data-for-its-innovative-prostate-cancer-test-proclarix-accepted-for-presentation-at-2025-european-association-of-urology-congress</link>
      <guid isPermaLink="true">https://6ix.com/company/onco-innovations-ltd-1/news/onconetix-announces-new-clinical-data-for-its-innovative-prostate-cancer-test-proclarix-accepted-for-presentation-at-2025-european-association-of-urology-congress</guid>
      <pubDate>Wed, 19 Mar 2025 12:00:00 GMT</pubDate>
      <description>CINCINNATI, March 19, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc., (Nasdaq: ONCO) (&amp;#x201C;Onconetix...</description>
    </item>
  </channel>
</rss>